J 233 (Oxcarbazepine 300 mg)
Pill imprint J 233 has been identified as Oxcarbazepine 300 mg.
Oxcarbazepine is used in the treatment of bipolar disorder; anxiety; neuropathic pain; epilepsy; seizures (and more), and belongs to the drug class dibenzazepine anticonvulsants. Risk cannot be ruled out during pregnancy. Oxcarbazepine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- J 233
- Strength:
- 300 mg
- Color:
- Orange
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Cadista Pharmaceuticals Inc.
- National Drug Code (NDC):
- 59746-0233
- Inactive Ingredients:
- silicon dioxide
crospovidone
hypromelloses
ferric oxide yellow
magnesium stearate
microcrystalline cellulose
polyethylene glycol
magnesium silicate
titanium dioxide
ferric oxide red
More about oxcarbazepine
Consumer resources
- Oxcarbazepine
- Oxcarbazepine extended-release tablets
- Oxcarbazepine suspension
- Oxcarbazepine (Advanced Reading)
- Other brands: Trileptal, Oxtellar XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
